Abstract

(1) Background: Bacillus anthracis is a spore-forming, Gram-positive bacterium causing anthrax, a zoonosis affecting mainly livestock. When occasionally infecting humans, B. anthracis provokes three different clinical forms: cutaneous, digestive and inhalational anthrax. More recently, an injectional anthrax form has been described in intravenous drug users. (2) Case presentation: We report here the clinical and microbiological features, as well as the strain phylogenetic analysis, of the only injectional anthrax case observed in France so far. A 27-year-old patient presented a massive dermohypodermatitis with an extensive edema of the right arm, and the development of drug-resistant shocks. After three weeks in an intensive care unit, the patient recovered, but the microbiological identification of B. anthracis was achieved after a long delay. (3) Conclusions: Anthrax diagnostic may be difficult clinically and microbiologically. The phylogenetic analysis of the Bacillus anthracis strain PF1 confirmed its relatedness to the injectional anthrax European outbreak group-II.

Highlights

  • Bacillus anthracis is a spore-forming, Gram-positive bacterium causing anthrax, a zoonosis affecting mainly livestock [1]

  • (2) Case presentation: We report here the clinical and microbiological features, as well as the strain phylogenetic analysis, of the only injectional anthrax case observed in France so far

  • We report here the clinical and microbiological features as well as the phylogenetic analysis of the strain responsible for the only injectional anthrax case observed in France so far

Read more

Summary

Introduction

Bacillus anthracis is a spore-forming, Gram-positive bacterium causing anthrax, a zoonosis affecting mainly livestock [1]. When infecting humans, it provokes classically three different clinical forms: cutaneous, digestive and inhalational anthrax. A fourth injectional form in intravenous drug users was described in 2000 [2]. Only two large outbreaks of injectional anthrax have been described, affecting mainly Northern European countries in two separate waves spanning 2009–2010 and 2012–2013, causing 70 cases and 26 fatalities [3]. We report here the clinical and microbiological features as well as the phylogenetic analysis of the strain responsible for the only injectional anthrax case observed in France so far

Case Presentation
Laboratory Identification
Ethic Statement
Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call